Close
Nordic 9Nordic 9

Graph Therapeutics (private company)

Austria graphtx.com
See something wrong or missing? Let us know
Offices:Vienna
Industry:Health servicesPharmaSoftware Services
Business model:B2B

Graph Therapeutics is a pharma startup in Austria developing a precision immunology techbio platform that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3.1M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Graph Therapeutics

Name Criteria
Germany Yendou
77%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Synapse Medicine
75%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
United Kingdom Baseimmune
75%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
France Inato
75%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
United Kingdom Causaly
75%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
United Kingdom CardiaTec Biosciences
75%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
France Raidium
75%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
France Qubit Pharmaceuticals
72%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
United Kingdom Verisian
72%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Carcinotech
72%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
Top